METHOD FOR TREATING ENDOTOXIC SHOCK AND INFLAMMATORY AND AUTOIMMUNE DISEASES IN MAMMALS

摘要

The invention relates to the utilization of therapeutic agents inhibiting the production of tumoral necrosis factor (TNF) and interleukin 6 (IL-6), which induce high levels of interleukin 4 (IL-4), in the treatment of endotoxic shock and inflammatory and autoimmune diseases in mammals. Said agents are the vasoactive intestinal peptide (VIP), the pituitary adenylate cyclase-activating peptide (PACAP) and their corresponding fragments and derivatives.